Stocks
Yarrow Bioscience, Inc.YARW
NASDAQHealthcareBiotechnology$20.17
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel therapies for infectious diseases, with a focus on antiviral candidates targeting respiratory pathogens. Its pipeline includes early-stage assets that have attracted attention from investors monitoring the infectious disease space, though the company has yet to generate revenue.
52W Range: $16.05-$46.95
Congressional Interest in Yarrow Bioscience, Inc. (YARW)
No congressional trades have been disclosed for Yarrow Bioscience, Inc. (YARW) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading YARW?
No congressional trades found for this stock.